Resco

Resco may be available in the countries listed below.

Ingredient matches for Resco

Risperidone

Risperidone is reported as an ingredient of Resco in the following countries:

• Bangladesh

International Drug Name Search

PMS-Cilazapril

PMS-Cilazapril may be available in the countries listed below.

Ingredient matches for PMS-Cilazapril

Cilazapril

Cilazapril monohydrate (a derivative of Cilazapril) is reported as an ingredient of PMS-Cilazapril in the following countries:

• Canada

International Drug Name Search

Spasmo-Urgenin

Spasmo-Urgenin may be available in the countries listed below.

Ingredient matches for Spasmo-Urgenin

Trospium

Trospium Chloride is reported as an ingredient of Spasmo-Urgenin in the following countries:

• Austria


• Bahrain


• Egypt


• Kuwait


• Qatar


• Saudi Arabia


• United Arab Emirates

International Drug Name Search

Ranitidina L.CH.

Ranitidina L.CH. may be available in the countries listed below.

Ingredient matches for Ranitidina L.CH.

Ranitidine

Ranitidine is reported as an ingredient of Ranitidina L.CH. in the following countries:

• Chile

International Drug Name Search

Perigard

Perigard may be available in the countries listed below.

Ingredient matches for Perigard

Perindopril

Perindopril erbumine (a derivative of Perindopril) is reported as an ingredient of Perigard in the following countries:

• Myanmar


• Vietnam

International Drug Name Search

Fanaxal

Fanaxal may be available in the countries listed below.

Ingredient matches for Fanaxal

Alfentanil

Alfentanil hydrochloride (anhydrous) (a derivative of Alfentanil) is reported as an ingredient of Fanaxal in the following countries:

• Spain

International Drug Name Search

Orimune Oral, Parenteral

Generic Name: poliovirus vaccine, inactivated (Injection route)

POE-lee-oh VYE-rus VAX-een, in-AK-ti-vated

Commonly used brand name(s)

In the U.S.

• Ipol

Available Dosage Forms:

• Injectable


• Suspension

Therapeutic Class: Vaccine

Uses For Orimune

Poliovirus vaccine is an active immunizing agent used to prevent poliomyelitis (polio). It works by causing your body to produce its own protection (antibodies) against the virus that causes polio.

There are two types of polio vaccine that are given by injection, poliovirus vaccine inactivated (IPV) and poliovirus vaccine inactivated enhanced potency (eIPV). In the U.S. and Canada, the type of vaccine that is given by injection is eIPV. The type of vaccine that is given by mouth is called poliovirus vaccine live oral (OPV).

Polio is a very serious infection that causes paralysis of the muscles, including the muscles that enable you to walk and breathe. A polio infection may leave a person unable to breathe without the help of an iron lung, unable to walk without leg braces, or confined to a wheelchair. There is no cure for polio.

Immunization against polio is recommended for all infants from 6 to 12 weeks of age, all children, all adolescents up to 18 years of age, and certain adults who are at greater risk for exposure to polioviruses than the general population, including:

• Persons traveling to areas or countries where polio is uncontrolled, whether or not they have been vaccinated against polio in the past.


• Persons who live in areas where polio infection still occurs.


• Adults who have not been vaccinated or who have not had the complete series of vaccinations against polio and who live in households with children who are to be given the oral polio vaccine (OPV).


• Employees in day-care centers and group homes for children, such as orphanages.


• Employees in medical facilities, such as hospitals and doctors' offices.


• Laboratory workers handling samples that may contain polio viruses.

Immunization against polio is not recommended for infants younger than 6 weeks of age, because antibodies they received from their mothers before birth may interfere with the effectiveness of the vaccine. Infants who were immunized against polio before 6 weeks of age should receive the complete polio immunization series.

This vaccine is to be administered only by or under the supervision of your doctor or other health care professional.

Before Using Orimune

In deciding to use a vaccine, the risks of taking the vaccine must be weighed against the good it will do. This is a decision you and your doctor will make. For this vaccine, the following should be considered:

For a while after you are immunized, there is a very small risk (1 in 2.2 million) that any persons living in your household who have not yet been immunized against polio or who have or had an immune deficiency condition may develop poliomyelitis (polio) from being around you. Talk to your doctor if you have any questions about this.

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Use is not recommended for infants up to 6 weeks of age. For infants and children 6 weeks of age and older, polio vaccine is not expected to cause different side effects or problems than it does in adults.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of polio vaccine in the elderly with use in other age groups, this vaccine is not expected to cause different side effects or problems in older persons than it does in younger adults.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of this vaccine. Make sure you tell your doctor if you have any other medical problems, especially:

• Diarrhea or


• Virus infection or


• Vomiting—These conditions may reduce the useful effect of the vaccine.

• Fever or


• Illness (moderate or severe) or


• Weakness (severe)—The symptoms of these conditions may be confused with possible side effects of the vaccine.

• Immune deficiency condition, family history of—May increase the chance of side effects with the vaccine.

Proper Use of poliovirus vaccine, inactivated

This section provides information on the proper use of a number of products that contain poliovirus vaccine, inactivated. It may not be specific to Orimune. Please read with care.

A nurse or other trained health professional will give you or your child this vaccine in a hospital. This vaccine is given as a shot into your muscle or under your skin.

In children, a total of 4 shots of polio vaccine are given. The shots are usually given at 2 months, 4 months, 6 to 18 months, and 4 to 6 years of age. Each dose of this vaccine is usually given at least 4 weeks apart. The first dose of this vaccine may be given to infants 6 weeks of age.

This vaccine needs to be given on a fixed schedule. If you or your child miss a scheduled shot, call your doctor to make another appointment as soon as possible.

Precautions While Using Orimune

Tell your doctor that you have received this vaccine if you plan to get any live virus vaccines within 1 month after receiving this vaccine.

Orimune Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur:

Symptoms of allergic reaction

• Difficulty with breathing or swallowing


• hives


• itching, especially of the feet or hands


• reddening of the skin, especially around ears


• swelling of the eyes, face, or inside of the nose


• unusual tiredness or weakness (sudden and severe)

More common

• Fever over 102° F (39° C)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

• Irritability


• loss of appetite


• tiredness

Less common

• Itching or skin rash


• redness, soreness, hard lump, tenderness, or pain at the place of injection

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Orimune Oral, Parenteral side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Orimune Oral, Parenteral resources

• Orimune Oral, Parenteral Side Effects (in more detail)
• Orimune Oral, Parenteral Use in Pregnancy & Breastfeeding
• Orimune Oral, Parenteral Drug Interactions
• Orimune Oral, Parenteral Support Group
• 0 Reviews for Orimune Oral, Parenteral - Add your own review/rating

Compare Orimune Oral, Parenteral with other medications

• Poliomyelitis Prophylaxis

Pramocaina

Pramocaina may be available in the countries listed below.

Ingredient matches for Pramocaina

Pramocaine

Pramocaina (DCIT) is also known as Pramocaine (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Enacodan

Enacodan may be available in the countries listed below.

Ingredient matches for Enacodan

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enacodan in the following countries:

• Denmark

International Drug Name Search

Phenylephrine hydrochloride Chauvin

Phenylephrine hydrochloride Chauvin may be available in the countries listed below.

Ingredient matches for Phenylephrine hydrochloride Chauvin

Phenylephrine

Phenylephrine hydrochloride (a derivative of Phenylephrine) is reported as an ingredient of Phenylephrine hydrochloride Chauvin in the following countries:

• Sweden

International Drug Name Search

Helopan

Helopan may be available in the countries listed below.

Ingredient matches for Helopan

Pancreatin

Pancreatin is reported as an ingredient of Helopan in the following countries:

• Germany

International Drug Name Search

Formotec

Formotec may be available in the countries listed below.

Ingredient matches for Formotec

Formoterol

Formoterol fumarate (a derivative of Formoterol) is reported as an ingredient of Formotec in the following countries:

• Venezuela

International Drug Name Search

Omnigeriat

Omnigeriat may be available in the countries listed below.

Ingredient matches for Omnigeriat

Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Omnigeriat in the following countries:

• Argentina

International Drug Name Search

Pramiracetam

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N06BX16

CAS registry number (Chemical Abstracts Service)

0068497-62-1

Chemical Formula

C14-H27-N3-O2

Molecular Weight

269

Therapeutic Categories

Central stimulant

Nootropic

Chemical Name

1-Pyrrolidineacetamide, N-[2-[bis(1-methylethyl)amino]ethyl]-2-oxo

Foreign Names

• Pramiracetamum (Latin)
• Pramiracetam (German)
• Pramiracetam (French)
• Pramiracetam (Spanish)

Generic Names

• Amacetam (IS)
• Pramiracetam Sulfate (OS: USAN)
• CI 879 (IS: Parke-Davis)

Brand Names

• Pramistar
  Firma, Latvia; Menarini, Lithuania; Berlin-Chemie, Romania

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cylence

Cylence may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cylence

Cyfluthrin

Cyfluthrin is reported as an ingredient of Cylence in the following countries:

• Australia


• South Africa

Piperonyl Butoxide

Piperonyl Butoxide is reported as an ingredient of Cylence in the following countries:

• Australia

International Drug Name Search

Clindamycin Alternova

Clindamycin Alternova may be available in the countries listed below.

Ingredient matches for Clindamycin Alternova

Clindamycin

Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clindamycin Alternova in the following countries:

• Austria

International Drug Name Search

Rebetol

Pronunciation: RYE-ba-VIR-in
Generic Name: Ribavirin
Brand Name: Examples include Rebetol and Ribasphere

Rebetol may cause serious birth defects and/or fetal death when used during pregnancy. It should not be used by women who are pregnant or by men whose female partners are pregnant. Women of childbearing potential who either take Rebetol or are sexual partners of men who take Rebetol must:

• have a negative pregnancy test immediately before therapy with Rebetol is started.


• avoid becoming pregnant during therapy with Rebetol or within the first 6 months after Rebetol is stopped.

At least 2 reliable forms of effective birth control must be used during treatment with Rebetol and for 6 months after treatment with Rebetol is stopped.

Use of Rebetol alone is not effective for treating chronic hepatitis C infection. Rebetol must be used with another medicine (interferon) in order to treat hepatitis C infection.

Rebetol may cause serious blood problems (hemolytic anemia), which can cause serious and sometimes fatal heart attacks in patients who have heart disease. Do not take Rebetol if you have a history of serious or uncontrolled heart problems.

Rebetol is used for:

Treating chronic hepatitis C infection in certain patients when used in combination with interferon. It may also be used for other conditions as determined by your doctor.

Rebetol is an antiviral medicine. Exactly how it works to treat hepatitis C is not known.

Do NOT use Rebetol if:

• you are allergic to any ingredient in Rebetol or have had a severe allergic reaction (eg, red, swollen, blistered, or peeling skin) to ribavirin or any other ingredient in Rebetol


• you are pregnant or planning to become pregnant while you take Rebetol or within 6 months after you stop taking it


• you are a man with a female sexual partner who is pregnant or planning to become pregnant while you take Rebetol or within 6 months after you stop taking it


• you have certain blood disorders (eg, hemolytic anemia, sickle-cell anemia, thalassemia major), a history of serious or uncontrolled heart problems, severe kidney problems, or inflammation of the pancreas (acute pancreatitis)


• you have autoimmune hepatitis (liver problems caused by your body instead of a virus)


• you are taking didanosine

Contact your doctor or health care provider right away if any of these apply to you.

Before using Rebetol:

Some medical conditions may interact with Rebetol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you have a female sexual partner who is of childbearing age


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of cancer, heart problems or a heart attack, high blood pressure, kidney problems, diabetes, pancreas problems, lung or breathing problems, sarcoidosis, blood problems (eg, anemia, spherocytosis), stomach or bowel bleeding, thyroid problems, HIV infection or other immune system problems, or eye or vision problems


• if you have liver problems other than hepatitis C infection (eg, hepatitis B infection), cirrhosis of the liver, or decreased liver function


• if you have a history of anxiety or other mood or mental disorders (eg, depression), thoughts of suicide, or suicidal behavior


• if you have used interferon before to treat hepatitis C and it did not work


• if you had an organ transplant


• if you have a history of drug or alcohol abuse

Some MEDICINES MAY INTERACT with Rebetol. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Didanosine or other nucleoside reverse transcriptase inhibitors (NRTIs) (eg, lamivudine), other antiretroviral medicines for HIV infection, or thiopurines (eg, azathioprine) because serious side effects, including risk of infection, nerve problems (peripheral neuropathy), pancreas problems, bone marrow suppression, lactic acidosis, and severe or fatal liver failure, may be increased by Rebetol


• Anticoagulants (eg, warfarin) or certain NRTIs (eg, lamivudine, stavudine, zidovudine) because their effectiveness may be decreased by Rebetol

This may not be a complete list of all interactions that may occur. Ask your health care provider if Rebetol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Rebetol:

Use Rebetol as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Rebetol comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Rebetol refilled.


• Take Rebetol by mouth with food.


• Swallow Rebetol whole. Do not break, crush, or chew before swallowing.


• Drinking extra fluids while you are taking Rebetol is recommended. Check with your doctor for instructions.


• Taking Rebetol at the same time each day will help you remember to take it.


• Take Rebetol on a regular schedule to get the most benefit from it.


• Continue to use Rebetol even if you feel well. Do not miss any doses.


• If you miss a dose of Rebetol, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Rebetol.

Important safety information:

• Rebetol may cause dizziness or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Rebetol with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Avoid drinking alcohol, including beer, wine, and liquor, because it could worsen liver disease.


• At least 2 reliable forms of effective birth control must be used during treatment by men and women who take Rebetol and for 6 months after Rebetol is stopped. Men who take Rebetol should use a condom with spermicide as 1 of the 2 forms of birth control.


• Women of childbearing potential who either take Rebetol or are sexual partners of men who take Rebetol must have a pregnancy test before therapy with Rebetol is started, monthly during therapy, and monthly for 6 months after Rebetol is stopped.


• Children and teenagers who take Rebetol may be at increased risk of suicidal thoughts or actions. Adults may also be affected. The risk may be greater in patients who have had suicidal thoughts or actions in the past. Watch patients who take Rebetol closely. Contact the doctor at once if new, worsened, or sudden symptoms such as depressed mood, aggression, anger, anxiety, nervousness, irritable behavior, or any unusual changes in mood or behavior occur. Contact the doctor right away if any signs of suicidal thoughts or actions occur.


• Rebetol may lower the ability of your body to fight infection. Avoid contact with people who have colds or infections. Tell your doctor if you notice signs of infection like fever, sore throat, rash, or chills.


• Rebetol may cause dry mouth and increase the risk of teeth and gum problems. Proper dental care is important while you are taking Rebetol. Brush and floss your teeth carefully at least twice a day and visit the dentist regularly.


• If vomiting occurs while you are taking Rebetol, be sure to rinse your mouth and clean your teeth afterwards.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• Diabetes patients - Rebetol may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.


• Lab tests, including pregnancy; complete blood cell counts; hemoglobin or hematocrit levels; heart, liver, kidney, thyroid, and lung function; and eye exams, may be performed while you use Rebetol. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Rebetol with caution in the ELDERLY; they may be more sensitive to its effects, especially anemia.


• Rebetol may affect growth rate in CHILDREN and teenagers in some cases. They may need regular growth checks while they take Rebetol.


• Use Rebetol with extreme caution in CHILDREN younger than 3 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Do not use Rebetol if you are pregnant. Avoid becoming pregnant while you are taking it. If you think you may be pregnant, contact your doctor right away. It is not known if Rebetol is found in breast milk. Do not breast-feed while taking Rebetol.

Possible side effects of Rebetol:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; cough; diarrhea; dizziness; dry mouth; dry skin; loss of appetite; mild headache, nausea, or vomiting; sinus problems; tiredness; upset stomach; weakness or fatigue.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; itching; tightness in the chest; swelling of the mouth, face, lips, or tongue); changes in hearing, taste, or vision; chest pain; dark, tarry, or bloody stools; dark urine; decrease in the amount of urine; fainting; fever, chills, or sore throat; hair loss; joint pain; menstrual problems; mood or mental problems (eg, agitation, aggression, anger, anxiety, decreased concentration, depression, irritability, nervousness); muscle pain or weakness; numbness of an arm or leg; pale stools; prolonged nausea and vomiting; rapid breathing; red, swollen, blistered, or peeling skin; severe headache; severe or persistent diarrhea; severe stomach or back pain; shortness of breath; suicidal thoughts or actions; trouble sleeping; unusual bruising or bleeding; unusual or severe tiredness, weakness, or fatigue; weight loss; yellowing of the eyes or skin.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Rebetol side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Rebetol:

Store Rebetol at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Rebetol out of the reach of children and away from pets.

General information:

• If you have any questions about Rebetol, please talk with your doctor, pharmacist, or other health care provider.


• Rebetol is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Rebetol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Rebetol resources

• Rebetol Side Effects (in more detail)
• Rebetol Dosage
• Rebetol Use in Pregnancy & Breastfeeding
• Drug Images
• Rebetol Drug Interactions
• Rebetol Support Group
• 0 Reviews for Rebetol - Add your own review/rating

• Rebetol Advanced Consumer (Micromedex) - Includes Dosage Information


• Rebetol Consumer Overview


• Rebetol Prescribing Information (FDA)


• Ribavirin Prescribing Information (FDA)


• Ribavirin Professional Patient Advice (Wolters Kluwer)


• Ribavirin Monograph (AHFS DI)


• Copegus Prescribing Information (FDA)


• Ribasphere Prescribing Information (FDA)


• Ribasphere Consumer Overview


• Virazole Prescribing Information (FDA)


• Virazole Advanced Consumer (Micromedex) - Includes Dosage Information

Compare Rebetol with other medications

• Hepatitis C

Dasovas

Dasovas may be available in the countries listed below.

Ingredient matches for Dasovas

Nicergoline

Nicergoline is reported as an ingredient of Dasovas in the following countries:

• Peru

International Drug Name Search

Piracétam RPG

Piracétam RPG may be available in the countries listed below.

Ingredient matches for Piracétam RPG

Piracetam

Piracetam is reported as an ingredient of Piracétam RPG in the following countries:

• France

International Drug Name Search

Bezafibrat AL

Bezafibrat AL may be available in the countries listed below.

Ingredient matches for Bezafibrat AL

Bezafibrate

Bezafibrate is reported as an ingredient of Bezafibrat AL in the following countries:

• Germany

International Drug Name Search

Enalapril + Idroclorotiazide ratiopharm

Enalapril + Idroclorotiazide ratiopharm may be available in the countries listed below.

Ingredient matches for Enalapril + Idroclorotiazide ratiopharm

Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Enalapril + Idroclorotiazide ratiopharm in the following countries:

• Italy

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Enalapril + Idroclorotiazide ratiopharm in the following countries:

• Italy

International Drug Name Search

Clopix

Clopix may be available in the countries listed below.

Ingredient matches for Clopix

Clopidogrel

Clopidogrel is reported as an ingredient of Clopix in the following countries:

• Tunisia

International Drug Name Search

Arketis

Arketis may be available in the countries listed below.

Ingredient matches for Arketis

Paroxetine

Paroxetine is reported as an ingredient of Arketis in the following countries:

• Poland


• Slovakia

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Arketis in the following countries:

• Estonia


• Latvia


• Lithuania


• Malta


• Romania

International Drug Name Search

Metoprolol Genericon

Metoprolol Genericon may be available in the countries listed below.

Ingredient matches for Metoprolol Genericon

Metoprolol

Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol Genericon in the following countries:

• Austria

International Drug Name Search

Dolasetron

Pronunciation: doe-LAS-e-tron
Generic Name: Dolasetron
Brand Name: Anzemet

Dolasetron is used for:

Preventing and treating nausea and vomiting after surgery in adults and children 2 years old and older.

Dolasetron is a serotonin 5-HT₃ receptor blocker. It works by blocking a substance thought to be a cause of nausea and vomiting in certain situations.

Do NOT use Dolasetron if:

• you are allergic to any ingredient in Dolasetron


• you are using Dolasetron to prevent nausea and vomiting caused by cancer chemotherapy


• you have a certain type of irregular heartbeat (congenital long QT syndrome), or uncorrected low blood potassium or magnesium levels


• you have or are at risk of complete heart block and do not have a pacemaker


• you are taking apomorphine or nilotinib

Contact your doctor or health care provider right away if any of these apply to you.

Before using Dolasetron:

Some medical conditions may interact with Dolasetron. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have had a severe allergic reaction (eg, severe rash, hives, difficulty breathing, dizziness) to another serotonin 5-HT₃ receptor blocker (eg, ondansetron, granisetron)


• if you have a history of heart problems (eg, slow or irregular heartbeat, sick sinus syndrome, a heart attack, heart failure), kidney problems, or low potassium or magnesium levels in the blood


• if a member of your family has a history of a certain type of irregular heartbeat (congenital long QT syndrome)


• if you are taking medicines that may cause certain types of irregular heartbeat (eg, flecainide, verapamil, quinidine)

Some MEDICINES MAY INTERACT with Dolasetron. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Anthracyclines (eg, doxorubicin), antiarrhythmics (eg, amiodarone, dofetilide, sotalol), arsenic, astemizole, atenolol, bepridil, chloroquine, cimetidine, cisapride, diuretics (eg, furosemide), domperidone, droperidol, halofantrine, haloperidol, histone deacetylase inhibitors (eg, romidepsin), iloperidone, ketolides (eg, telithromycin), lithium, macrolides (eg, erythromycin), maprotiline, methadone, nilotinib, paliperidone, pentamidine, phenothiazines (eg, thioridazine), pimozide, quinolones (eg, levofloxacin), streptogramins (eg, quinupristin/dalfopristin), terfenadine, tetrabenazine, tricyclic antidepressants (eg, amitriptyline), tyrosine kinase inhibitors (eg, sunitinib), or ziprasidone because the risk of irregular heart rhythm is increased


• Apomorphine because the risk of severe low blood pressure or loss of consciousness may be increased


• Rifampin because it may decrease Dolasetron's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dolasetron may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Dolasetron:

Use Dolasetron as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Dolasetron is usually administered as an injection at your doctor's office, hospital, or clinic.


• Do not use Dolasetron if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.


• Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.


• If you miss a dose of Dolasetron, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Dolasetron.

Important safety information:

• Dolasetron may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Dolasetron with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Dolasetron may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Do NOT use more than the recommended dose without checking with your doctor.


• Tell your doctor or dentist that you use Dolasetron before you receive any medical or dental care, emergency care, or surgery.


• Lab tests, including electrocardiograms (ECGs), and blood potassium and magnesium levels, may be performed while you use Dolasetron. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Use Dolasetron with caution in the ELDERLY; they may be more sensitive to its effects, especially irregular heartbeat.


• Dolasetron should be used with extreme caution in CHILDREN younger than 2 years old; safety and effectiveness in these children have not been confirmed.


• Caution is advised when using Dolasetron in CHILDREN; they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Dolasetron while you are pregnant. It is not known if Dolasetron is found in breast milk. If you are or will be breast-feeding while you use Dolasetron, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Dolasetron:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Dizziness; headache; tiredness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); change in heartbeat (including fast or slow heartbeat) or irregular heartbeat; chest pain; fainting; lightheadedness; numbness or pain of an arm or leg; pounding in the chest; shortness of breath; sudden, severe headache, stomach pain, dizziness, or vomiting; sudden vision changes; urination problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Dolasetron side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include fainting; irregular heartbeat; severe dizziness.

Proper storage of Dolasetron:

Dolasetron is usually handled and stored by a health care provider. If you are using Dolasetron at home, store Dolasetron as directed by your pharmacist or health care provider. Do not store in the bathroom. Keep Dolasetron out of the reach of children and away from pets.

General information:

• If you have any questions about Dolasetron, please talk with your doctor, pharmacist, or other health care provider.


• Dolasetron is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dolasetron. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dolasetron resources

• Dolasetron Side Effects (in more detail)
• Dolasetron Use in Pregnancy & Breastfeeding
• Dolasetron Drug Interactions
• Dolasetron Support Group
• 0 Reviews for Dolasetron - Add your own review/rating

• dolasetron Advanced Consumer (Micromedex) - Includes Dosage Information


• Anzemet Prescribing Information (FDA)


• Anzemet Monograph (AHFS DI)


• Anzemet Consumer Overview


• Anzemet Advanced Consumer (Micromedex) - Includes Dosage Information

Compare Dolasetron with other medications

• Nausea/Vomiting, Chemotherapy Induced
• Nausea/Vomiting, Postoperative

ratio-Venlafaxine

ratio-Venlafaxine may be available in the countries listed below.

Ingredient matches for ratio-Venlafaxine

Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of ratio-Venlafaxine in the following countries:

• Canada

International Drug Name Search

Amitriptylin Nycomed

Amitriptylin Nycomed may be available in the countries listed below.

Ingredient matches for Amitriptylin Nycomed

Amitriptyline

Amitriptyline hydrochloride (a derivative of Amitriptyline) is reported as an ingredient of Amitriptylin Nycomed in the following countries:

• Estonia


• Georgia

International Drug Name Search

Amoxicilline / Acide Clavulanique Biogaran

Amoxicilline/Acide Clavulanique Biogaran may be available in the countries listed below.

Ingredient matches for Amoxicilline/Acide Clavulanique Biogaran

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline/Acide Clavulanique Biogaran in the following countries:

• France

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicilline/Acide Clavulanique Biogaran in the following countries:

• France

International Drug Name Search

Glycopyrronium Bromide

In some countries, this medicine may only be approved for veterinary use.

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000596-51-0

Chemical Formula

C19-H28-Br-N-O3

Molecular Weight

398

Therapeutic Categories

Antispasmodic agent

Parasympatholytic agent

Gastric acid secretion inhibitor

Chemical Name

Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-, bromide

Foreign Names

• Glycopyrronii Bromidum (Latin)
• Glycopyrronium bromid (German)
• Bromure de Glycopyrronium (French)
• Bromuro de glicopirronio (Spanish)

Generic Names

• Glycopyrrolate (OS: USAN)
• Glycopyrronium Bromide (OS: BAN)
• AHR 504 (IS: Robins)
• Glycopyrrolate (PH: USP 32)

Brand Names

• Glyco-P
  Khalendlwal, Ethiopia; Khandelwal, Myanmar



• Glycopyrodyn
  Excelsior, Taiwan



• Glycopyrrolate
  American Regent, United States; CorePharma, United States; Dr. Reddy's, United States; Kali, United States; Khandelwal, India; Ranbaxy, United States; Rising Pharmaceuticals, United States; Sandoz, Canada; URL, United States; Vintage, United States; West-Ward, United States



• Glycopyrrolate (veterinary use)
  IVX, United States



• Glycosate Vet (veterinary use)
  Nature Vet, Australia



• Robinul V (veterinary use)
  Laboratoire Vétoquinol, France



• Robinul
  Aspen Pharmacare, South Africa; Baxter, United States; Eumedica, Belgium; Eumedica, Luxembourg; Goldshield, United Arab Emirates; Goldshield, Bahrain; Goldshield, Egypt; Goldshield, United Kingdom; Goldshield, Iraq; Goldshield, Iran; Goldshield, Jordan; Goldshield, Kuwait; Goldshield, Lebanon; Goldshield, Oman; Goldshield, Qatar; Goldshield, Saudi Arabia; Goldshield, Syria; Goldshield, Yemen; Healthcare Logistics, New Zealand; Meda, Denmark; Meda, Finland; Meda, Norway; Meda, Sweden; Riemser, Germany; Shionogi, United States; Sigma, Australia



• Robinul (veterinary use)
  Fort Dodge Animale Health, United States; Goldshield, United Kingdom



• Robinul-Neostigmine (Glycopyrronium Bromide and Neostigmine)
  Eumedica, Belgium; Meda, Denmark; Meda, Norway; Meda, Sweden; Sintetica, Switzerland

International Drug Name Search

Glossary

BAN	British Approved Name
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Cytisine

CAS registry number (Chemical Abstracts Service)

0000485-35-8

Chemical Formula

C11-H14-N2-O

Molecular Weight

190

Therapeutic Category

Analeptic

Chemical Name

1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R)-

Foreign Names

• Cytisin (German)
• Cytisine (French)
• Citisina (Spanish)

Generic Names

• Baptitoxin (IS)
• Laburnin (IS)
• Sophorin (IS)
• Ulexin (IS)

Brand Names

• Tabex
  Briz, Latvia; Sopharma, Bulgaria; Sopharma, Georgia; Sopharma, Poland; Sopharma, Russian Federation

International Drug Name Search

Glossary

IS	Inofficial Synonym

Click for further information on drug naming conventions and International Nonproprietary Names.

Ramil

Ramil may be available in the countries listed below.

Ingredient matches for Ramil

Ramipril

Ramipril is reported as an ingredient of Ramil in the following countries:

• Bangladesh


• Czech Republic


• Iceland


• Slovakia

International Drug Name Search

Recombivax HB

Pronunciation: hep-ah-TY-tiss
Generic Name: Hepatitis B Vaccine (Recombinant)
Brand Name: Examples include Engerix-B and Recombivax HB

Recombivax HB is used for:

Preventing hepatitis B infection.

Recombivax HB is a vaccine. It works by stimulating the body to produce antibodies against hepatitis B infection.

Do NOT use Recombivax HB if:

• you are allergic to any ingredient in Recombivax HB, including yeast


• you have had an allergic reaction to a hepatitis B vaccine in the past

Contact your doctor or health care provider right away if any of these apply to you.

Before using Recombivax HB:

Tell your health care provider if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you are allergic to latex


• if you have a weakened immune system, heart or lung disease, a fever, an infection, an illness, a tumor, or multiple sclerosis


• if you are on dialysis, you have or might have been recently exposed to hepatitis B, or if you have traveled to areas that are high-risk for hepatitis B


• if the patient is a premature infant

Some MEDICINES MAY INTERACT with Recombivax HB. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Immunosuppressive therapy (eg, cyclosporine) because it may decrease Recombivax HB's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Recombivax HB may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Recombivax HB:

Use Recombivax HB as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Recombivax HB is usually given as an injection at your doctor's office, hospital, or clinic. Contact your health care provider if you have any questions.


• If you miss a dose of Recombivax HB, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Recombivax HB.

Important safety information:

• Recombivax HB has noninfectious hepatitis B antigens in it. It cannot cause you to develop the hepatitis B infection.


• Before receiving this vaccine, tell your doctor about any illnesses you may have or if you are sick.


• For Recombivax HB to be effective, you must complete all doses. It is best to begin the vaccinations 6 months before travel, if possible, if that is the reason for receiving the vaccination.


• Contact your doctor at once if you are exposed to the virus through blood, a human bite, or sexual contact.


• The length of protection against the virus from Recombivax HB is not known, nor is it a guarantee that the vaccine will protect you from the hepatitis B virus.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Recombivax HB during pregnancy. It is unknown if Recombivax HB is excreted in breast milk. If you are or will be breast-feeding while you are using Recombivax HB, check with your doctor or pharmacist to discuss the risks to your baby.

Possible side effects of Recombivax HB:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; dizziness; fatigue; general feeling of discomfort; headache; irritability; loss of appetite; mild fever or sore throat; nausea; pain, swelling, or redness at the injection site; runny nose; tiredness; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); fainting; fast or irregular heartbeat; red, swollen, blistered, or peeling skin; severe or persistent dizziness; unusual bruising or bleeding.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Recombivax HB side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Recombivax HB:

Recombivax HB is usually handled and stored by a health care provider. If you are using Recombivax HB at home, store Recombivax HB as directed by your pharmacist or health care provider. Keep Recombivax HB out of the reach of children and away from pets.

General information:

• If you have any questions about Recombivax HB, please talk with your doctor, pharmacist, or other health care provider.


• Recombivax HB is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Recombivax HB. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Recombivax HB resources

• Recombivax HB Side Effects (in more detail)
• Recombivax HB Use in Pregnancy & Breastfeeding
• Recombivax HB Drug Interactions
• Recombivax HB Support Group
• 0 Reviews for Recombivax HB - Add your own review/rating

• Recombivax HB Advanced Consumer (Micromedex) - Includes Dosage Information


• Recombivax HB Concise Consumer Information (Cerner Multum)


• Engerix-B Pediatric Concise Consumer Information (Cerner Multum)

Compare Recombivax HB with other medications

• Hepatitis B Prevention

Rocephin Roche

Rocephin Roche may be available in the countries listed below.

Ingredient matches for Rocephin Roche

Ceftriaxone

Ceftriaxone disodium salt (a derivative of Ceftriaxone) is reported as an ingredient of Rocephin Roche in the following countries:

• Austria

International Drug Name Search

Biohist LA Sustained-Release Tablets

Pronunciation: klor-fen-IHR-ah-meen/sue-do-eh-FED-rin
Generic Name: Chlorpheniramine/Pseudoephedrine
Brand Name: Examples include Biohist LA and Chlor-Trimeton Decongestant

Biohist LA Sustained-Release Tablets are used for:

Relieving symptoms of sinus congestion, sinus pressure, runny nose, and sneezing due to colds, upper respiratory infections, and allergies. It may also be used for other conditions as determined by your doctor.

Biohist LA Sustained-Release Tablets are an antihistamine and decongestant combination. The antihistamine works by blocking the action of histamine, which helps reduce symptoms such as watery eyes and sneezing. The decongestant promotes sinus and nasal drainage, relieving congestion and pressure.

Do NOT use Biohist LA Sustained-Release Tablets if:

• you are allergic to any ingredient in Biohist LA Sustained-Release Tablets


• you have severe high blood pressure, severe heart blood vessel disease, rapid heartbeat, or severe heart problems


• you take sodium oxybate (GHB) or if you have taken furazolidone or a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the last 14 days

Contact your doctor or health care provider right away if any of these apply to you.

Before using Biohist LA Sustained-Release Tablets:

Some medical conditions may interact with Biohist LA Sustained-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a fast, slow, or irregular heartbeat


• if you have a history of asthma, lung problems (eg, emphysema), adrenal gland problems (eg, adrenal gland tumor), heart problems, high blood pressure, diabetes, heart blood vessel problems, stroke, glaucoma, a blockage of your stomach or intestines, ulcers, a blockage of your bladder, trouble urinating, an enlarged prostate, seizures, or an overactive thyroid

Some MEDICINES MAY INTERACT with Biohist LA Sustained-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Beta-blockers (eg, propranolol), catechol-O-methyltransferase (COMT) inhibitors (eg, tolcapone), furazolidone, indomethacin, MAOIs (eg, phenelzine), sodium oxybate (GHB), or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Biohist LA Sustained-Release Tablets's side effects


• Digoxin or droxidopa because the risk of irregular heartbeat or heart attack may be increased


• Bromocriptine or hydantoins (eg, phenytoin) because the risk of their side effects may be increased by Biohist LA Sustained-Release Tablets


• Guanethidine, guanadrel, mecamylamine, methyldopa, or reserpine because their effectiveness may be decreased by Biohist LA Sustained-Release Tablets

This may not be a complete list of all interactions that may occur. Ask your health care provider if Biohist LA Sustained-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Biohist LA Sustained-Release Tablets:

Use Biohist LA Sustained-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Biohist LA Sustained-Release Tablets by mouth with or without food.


• Swallow Biohist LA Sustained-Release Tablets whole. Do not break, crush, or chew before swallowing. Some brands of Biohist LA Sustained-Release Tablets may be broken in half before they are taken. If you have difficulty swallowing the whole tablet, ask your pharmacist if your brand may be broken in half.


• If you miss a dose of Biohist LA Sustained-Release Tablets, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Biohist LA Sustained-Release Tablets.

Important safety information:

• Biohist LA Sustained-Release Tablets may cause dizziness, drowsiness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Biohist LA Sustained-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not take diet or appetite control medicines while you are taking Biohist LA Sustained-Release Tablets without checking with you doctor.


• Biohist LA Sustained-Release Tablets has pseudoephedrine in it. Before you start any new medicine, check the label to see if it has pseudoephedrine in it too. If it does or if you are not sure, check with your doctor or pharmacist.


• Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.


• If your symptoms do not get better within 5 to 7 days or if they get worse, check with your doctor.


• Biohist LA Sustained-Release Tablets may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Biohist LA Sustained-Release Tablets. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.


• Biohist LA Sustained-Release Tablets may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Biohist LA Sustained-Release Tablets for a few days before the tests.


• Tell your doctor or dentist that you take Biohist LA Sustained-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Use Biohist LA Sustained-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects.


• Caution is advised when using Biohist LA Sustained-Release Tablets in CHILDREN; they may be more sensitive to its effects.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Biohist LA Sustained-Release Tablets while you are pregnant. It is not known if Biohist LA Sustained-Release Tablets are found in breast milk. Do not breast-feed while taking Biohist LA Sustained-Release Tablets.

Possible side effects of Biohist LA Sustained-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Constipation; diarrhea; dizziness; drowsiness; excitability; headache; loss of appetite; nausea; nervousness or anxiety; trouble sleeping; upset stomach; vomiting; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); difficulty urinating or inability to urinate; fast or irregular heartbeat; hallucinations; seizures; severe dizziness, lightheadedness, or headache; tremor; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Biohist LA side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; hallucinations; seizures; severe dizziness, lightheadedness, or headache; severe drowsiness; unusually fast, slow, or irregular heartbeat; and vomiting.

Proper storage of Biohist LA Sustained-Release Tablets:

Store Biohist LA Sustained-Release Tablets at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Biohist LA Sustained-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Biohist LA Sustained-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Biohist LA Sustained-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Biohist LA Sustained-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Biohist LA resources

• Biohist LA Side Effects (in more detail)
• Biohist LA Use in Pregnancy & Breastfeeding
• Biohist LA Drug Interactions
• 0 Reviews for Biohist LA - Add your own review/rating

Compare Biohist LA with other medications

• Hay Fever
• Sinusitis

ZORprin

In the US, ZORprin (aspirin systemic) is a member of the following drug classes: platelet aggregation inhibitors, salicylates and is used to treat Angina, Angina Pectoris Prophylaxis, Ankylosing Spondylitis, Antiphospholipid Syndrome, Aseptic Necrosis, Back Pain, Fever, Heart Attack, Ischemic Stroke, Ischemic Stroke - Prophylaxis, Juvenile Rheumatoid Arthritis, Kawasaki Disease, Myocardial Infarction - Prophylaxis, Niacin Flush, Osteoarthritis, Pain, Prosthetic Heart Valves, Prosthetic Heart Valves - Mechanical Valves, Revascularization Procedures - Prophylaxis, Rheumatic Fever, Rheumatoid Arthritis, Sciatica, Systemic Lupus Erythematosus and Thromboembolic Stroke Prophylaxis.

US matches:

• ZORprin Controlled-Release Tablets


• Zorprin

Ingredient matches for ZORprin

Aspirin

Acetylsalicylic Acid is reported as an ingredient of ZORprin in the following countries:

• United States

International Drug Name Search

Sulfaprime

Sulfaprime may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Sulfaprime

Oxytetracycline

Oxytetracycline is reported as an ingredient of Sulfaprime in the following countries:

• Portugal

Sulfadimethoxine

Sulfadimethoxine is reported as an ingredient of Sulfaprime in the following countries:

• Portugal

International Drug Name Search

Mucovin

Mucovin may be available in the countries listed below.

Ingredient matches for Mucovin

Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Mucovin in the following countries:

• Finland

International Drug Name Search

Amoxicillina + Acido clavulanico DOC

Amoxicillina + Acido clavulanico DOC may be available in the countries listed below.

Ingredient matches for Amoxicillina + Acido clavulanico DOC

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina + Acido clavulanico DOC in the following countries:

• Italy

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicillina + Acido clavulanico DOC in the following countries:

• Italy

International Drug Name Search

Risperidona Winthrop

Risperidona Winthrop may be available in the countries listed below.

Ingredient matches for Risperidona Winthrop

Risperidone

Risperidone is reported as an ingredient of Risperidona Winthrop in the following countries:

• Portugal


• Spain

International Drug Name Search

Paracetamol Tablets

Ingredient matches for Paracetamol Tablets

Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Tablets in the following countries:

• United States

International Drug Name Search

Captopril-Mepha

Captopril-Mepha may be available in the countries listed below.

Ingredient matches for Captopril-Mepha

Captopril

Captopril is reported as an ingredient of Captopril-Mepha in the following countries:

• Portugal


• Switzerland

International Drug Name Search

Ciprofloxacina Winthrop

Ciprofloxacina Winthrop may be available in the countries listed below.

Ingredient matches for Ciprofloxacina Winthrop

Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacina Winthrop in the following countries:

• Portugal

International Drug Name Search

Amoxicillina + Acido clavulanico Alter

Amoxicillina + Acido clavulanico Alter may be available in the countries listed below.

Ingredient matches for Amoxicillina + Acido clavulanico Alter

Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicillina + Acido clavulanico Alter in the following countries:

• Italy

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicillina + Acido clavulanico Alter in the following countries:

• Italy

International Drug Name Search

Calmisal

Calmisal may be available in the countries listed below.

Ingredient matches for Calmisal

Calcitriol

Calcitriol is reported as an ingredient of Calmisal in the following countries:

• Japan

International Drug Name Search

Diabetex

Diabetex may be available in the countries listed below.

Ingredient matches for Diabetex

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Diabetex in the following countries:

• Austria

International Drug Name Search

Citalopram EG

Citalopram EG may be available in the countries listed below.

Ingredient matches for Citalopram EG

Citalopram

Citalopram is reported as an ingredient of Citalopram EG in the following countries:

• Luxembourg

Citalopram hydrobromide (a derivative of Citalopram) is reported as an ingredient of Citalopram EG in the following countries:

• Belgium


• France


• Italy

International Drug Name Search

Ophthalgy

Ophthalgy may be available in the countries listed below.

Ingredient matches for Ophthalgy

Cromoglicic Acid

Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Ophthalgy in the following countries:

• Japan

International Drug Name Search

Carboplatin Sindan

Carboplatin Sindan may be available in the countries listed below.

Ingredient matches for Carboplatin Sindan

Carboplatin

Carboplatin is reported as an ingredient of Carboplatin Sindan in the following countries:

• Romania

International Drug Name Search

Fluorouracile Mayne

Fluorouracile Mayne may be available in the countries listed below.

Ingredient matches for Fluorouracile Mayne

Fluorouracil

Fluorouracil is reported as an ingredient of Fluorouracile Mayne in the following countries:

• Denmark

International Drug Name Search